Insights

Innovative Gene Editing Prime Medicine’s proprietary Prime Editing technology offers a highly precise method to correct over 90 percent of known genetic mutations, indicating significant potential for partnerships and sales in gene therapy and personalized medicine markets.

Strategic Funding Growth The company’s recent substantial funding rounds—including $245 million—highlight strong investor confidence and potential for scaling operations, creating opportunities for collaboration with biotech and pharma firms seeking cutting-edge gene editing solutions.

Expanding Therapeutics With recent preclinical and clinical program launches targeting cystic fibrosis, alpha-1 antitrypsin deficiency, and autosomal recessive CGD, Prime Medicine is positioned to offer targeted genetic therapies, opening avenues for sales of reagents, tools, and complementary services.

Industry Collaborations Partnerships with key players like Bristol Myers Squibb for ex vivo T-cell therapies suggest opportunities to provide collaborative development tools, reagents, and supporting technologies in advanced immunotherapies.

Market Potential Operating in the fast-growing biotechnology research sector with a focus on transformative gene editing, Prime Medicine’s innovative platform and substantial financial backing make it an attractive partner for companies looking to expand into next-generation genetic medicines.

Similar companies to Prime Medicine, Inc.

Prime Medicine, Inc. Tech Stack

Prime Medicine, Inc. uses 8 technology products and services including Tableau, NetSuite, Amazon Simple Email Service, and more. Explore Prime Medicine, Inc.'s tech stack below.

  • Tableau
    Business Intelligence
  • NetSuite
    E-commerce
  • Amazon Simple Email Service
    Email
  • ServiceNow
    Miscellaneous
  • MuleSoft
    Platform As A Service
  • JSON
    Programming Languages
  • Greenhouse
    Recruitment Marketing
  • Google
    Search Engines

Media & News

Prime Medicine, Inc.'s Email Address Formats

Prime Medicine, Inc. uses at least 1 format(s):
Prime Medicine, Inc. Email FormatsExamplePercentage
FLast@primemedicine.comJDoe@primemedicine.com
91%
First.Last@primemedicine.comJohn.Doe@primemedicine.com
8%
Last.First@primemedicine.comDoe.John@primemedicine.com
1%

Frequently Asked Questions

Where is Prime Medicine, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s main headquarters is located at 60 First Street Cambridge, Massachusetts 02141 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Prime Medicine, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Prime Medicine, Inc. is a publicly traded company; the company's stock symbol is PRME.

What is Prime Medicine, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s official website is primemedicine.com and has social profiles on LinkedInCrunchbase.

What is Prime Medicine, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Prime Medicine, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, Prime Medicine, Inc. has approximately 187 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer And Board Member: A. R.Chief Technical Officer: A. L.Chief Business Officer: M. H.. Explore Prime Medicine, Inc.'s employee directory with LeadIQ.

What industry does Prime Medicine, Inc. belong to?

Minus sign iconPlus sign icon
Prime Medicine, Inc. operates in the Biotechnology Research industry.

What technology does Prime Medicine, Inc. use?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s tech stack includes TableauNetSuiteAmazon Simple Email ServiceServiceNowMuleSoftJSONGreenhouseGoogle.

What is Prime Medicine, Inc.'s email format?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s email format typically follows the pattern of FLast@primemedicine.com. Find more Prime Medicine, Inc. email formats with LeadIQ.

How much funding has Prime Medicine, Inc. raised to date?

Minus sign iconPlus sign icon
As of March 2026, Prime Medicine, Inc. has raised $5M in funding. The last funding round occurred on Aug 01, 2025 for $5M.

When was Prime Medicine, Inc. founded?

Minus sign iconPlus sign icon
Prime Medicine, Inc. was founded in 2019.

Prime Medicine, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA.  A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations.  

We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients.  Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.

Section iconCompany Overview

Headquarters
60 First Street Cambridge, Massachusetts 02141 United States
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PRME
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $5M

    Prime Medicine, Inc. has raised a total of $5M of funding over 7 rounds. Their latest funding round was raised on Aug 01, 2025 in the amount of $5M.

  • $100M$250M

    Prime Medicine, Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $5M

    Prime Medicine, Inc. has raised a total of $5M of funding over 7 rounds. Their latest funding round was raised on Aug 01, 2025 in the amount of $5M.

  • $100M$250M

    Prime Medicine, Inc.'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.